Error loading player: No playable sources found
Welcome – Day 3 and Session IV – CMC Strategy Evolution from Early to Late Stage to Post-Approval
Date
June 9, 2021
This product is not available for individual purchase, but it is available as part of the following products:
The CGTP 2021 Symposium will explore how to continue to adapt concepts applied to other biologics and how to establish novel approaches where they are needed.
Speaker
Session Speakers
Lyell Immunopharma, Inc.
Pfizer, Inc.
Bristol-Myers Squibb Company
Therapeutic Goods Administration (TGA)
Session Chairs
Health Canada
AEMPS
Related Products
Session V – Deep Dive Discussion
Join Session V Deep Dive Panel Discussion [https://live.remo…
Session IV – Deep Dive Discussion
Join Session IV Deep Panel Discussion [https://live.remo…
Session VII – Analytical Development Case Studies & Closing Remarks
Cell and gene therapy products represent a complex and evolving class of products where analytical development and characterization methods are not universally established and yet are critical to product development…
